516
Participants
Start Date
November 9, 2023
Primary Completion Date
July 31, 2025
Study Completion Date
October 31, 2025
Tirofiban
Tirofiban, a GPIIb/IIIa receptor inhibitor. Intravenous administration.
Aspirin tablet
Aspirin. Oral administration.
Clopidogrel tablet
Clopidogrel. Oral administration.
RECRUITING
Jun Ni, Beijing
RECRUITING
Beijing Shunyi Hospital, Beijing
RECRUITING
Meihekou Central Hospital, Meihekou
RECRUITING
The Second Affiliated Hospital of Harbin Medical University, Harbin
RECRUITING
Xuzhou Central Hospital, Xuzhou
RECRUITING
Jinan Central Hospital, Jinan
RECRUITING
Shengli Oilfield Central Hospital, Dongying
RECRUITING
The Second Hospital of Tianjin Medical University, Tianjing
WITHDRAWN
The Second Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
The First Affiliated Hospital of Xinxiang Medical Unversity, Xinxiang
RECRUITING
The First People's Hospital of Shangqiu, Shangqiu
RECRUITING
Deyang People's Hospital, Deyang
RECRUITING
Mianyang Central Hospital, Mianyang
RECRUITING
The First People's Hospital of Yibin, Yibin
RECRUITING
The Second People's Hospital of Yibin, Yibin
RECRUITING
Tibet Autonomous Region People's Hospital, Lhasa
RECRUITING
Beijing Shijitan Hospital, Capital Medical University, Beijing
RECRUITING
The First Hospital of Tsinghua University, Beijing
RECRUITING
Botou City Hospital, Botou
RECRUITING
Cangzhou Central Hospital, Cangzhou
RECRUITING
Yellow River SANMENXIA Hospital, Sanmenxia
RECRUITING
The second hospital of Baoding, Baoding
RECRUITING
Chengde Central Hospital, Chengde
RECRUITING
Affiliated Hospital of Chifeng University, Chifeng
RECRUITING
Hengshui People's Hospital, Hengshui
RECRUITING
North China University of Science and Technology Affiliated Hospital, Tangshan
Pharmaron (Chengdu) Clinical Services Co., Ltd.
UNKNOWN
Peking Union Medical College Hospital
OTHER